Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Combining laser hair removal with topical eflornithine is recommended for better results in treating unwanted facial hair.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Finasteride effectively treats male hair loss, improving growth and density.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

Cetuximab can cause eyelash growth, which is rare but manageable.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Sensitive skin often causes discomfort, affects many people, especially women and older adults, and should be managed with careful product selection.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The normal human prostate does not significantly affect blood DHT levels.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.